Ariad Pharmaceuticals Inc fka ARIA

[zuize]

Only a blind would not see Denner filing the proxy fight had helped pushing ARIA share price from the low $6 to $8s trading range. And then the stunning results from '113 was just like adding gasoline to the fire which helped pushing share price to the level.

It's obvious that Berger did not see/anticipate the stunning data from '113 that's why the focus of his 4-year plan announced in January was Iclusig and willing to spend/waste another $300 million of the company valuable cash on Iclusig clinical trials.

FDA's ban of Iclusig ion 2013 clearly shows Harvey Berger a disaster for the company. His tactic of employing those yes men in the company management and his BOD so that he could continue rewarding himself multi-million dollars/year while the company income has always in red is clearly a disgrace to any decent human being.